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ABSTRACT 
IS CURRENT EVIDENCE THAT AVOIDANCE OF INHALATION AGENTS AND 
OPIOIDS MAY DECREASE METASTASIS STRONG ENOUGH FOR CRNAS TO 
SHOW A WILLINGNESS TO CHANGE PRACTICE? 
by Michael Wesley Tillman 
December 2016 
Metastasis following the surgical resection of primary site breast cancer is a 
medical issue, which plagues mastectomy patients.  The intention of this project was to 
synthesize current literature in order to make a presentation and disseminate it to 
Certified Registered Nurse Anesthetists (CRNAs) in southern Mississippi and assess the 
providers' willingness to change practice. CRNAs took part in a Qualtrics survey after 
viewing a PowerPoint presentation of evidence regarding anesthesia and metastasis.  The 
presentation illustrated the anesthetic techniques and pharmacological agents utilized, 
which either mitigate or potentiate a patient's risk for metastasis.  The survey assessed for 
a willingness to change practice.  Results from the survey indicate a willingness to 
change current practice by 18 of the 32 participants based on the evidence presented. 
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CHAPTER I - INTRODUCTION 
The choices CRNAs make regarding anesthesia for their patients directly impact 
the patient's immediate well-being and their long-term prognosis (Snyder & Greenberg, 
2010).  One widely utilized strategy for the treatment of primary site solid breast 
carcinomas is surgery (Heaney & Buggy, 2012).  General anesthesia and surgery are 
known to play roles in the suppression and inhibition of the immune system (Barash, 
Cullen, Stoelting, Cahalan, & Stock, 2009).  Therefore, surgical removal of the tumor 
with the use of general anesthesia may place the patient at risk for future metastasis.  
Risks associated with the surgical removal of cancer may be alleviated or exacerbated by 
the anesthetics and analgesics the patient receives before, during, and after the operative 
procedure (Heaney & Buggy, 2012).  Evidence is accumulating suggesting that a 
multimodal approach to the anesthetic management of this patient population may 
decrease cancer recurrence following mastectomy surgery. 
Clinical Question 
Is there a willingness to change practice when CRNAs are provided with current 
evidence related to which anesthetic techniques influence the surgical mastectomy 
patient's risk of metastasis?  Numerous techniques exist to provide anesthesia and 
analgesia to this patient population.  Opioids and inhalation agents have been found to 
increase a patient's risk for metastasis while other techniques, such as the use of neuraxial 
blockade, regional anesthesia, and a multimodal approach, decrease the risk 
(Exadaktylos, Buggy, Moriarty, Mascha, & Sessler, 2006; Heaney & Buggy, 2012; 
Snyder & Greenberg, 2010). 
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Purpose of the Project 
The purpose of this doctoral project was to assess the willingness of CRNAs to 
change practice when presented with a synthesis of current evidence from the literature 
related to anesthesia and metastasis.  The synthesis illustrates which anesthetic techniques 
and pharmacological agents may either mitigate or potentiate a patient's risk for 
metastasis.  The project explores ways to improve not only the mastectomy patient's 
experience throughout the operative period but also recognize the contributions of 
anesthesia and analgesia and how those factors can improve the patient's health long-term 
(Heaney & Buggy, 2012).  Multimodal anesthesia approaches the pain experienced by a 
patient during surgery using a variety of routes instead of the single approach of opioids 
(Peters, Brayton, & Erickson, 2006).  The patient who receives a multimodal approach to 
care, such as a regional or neuraxial blockade coupled with cyclooxygenase (COX) 
inhibitors and sedatives, requires less inhalation agent and fewer opioids throughout the 
perioperative period (Hodgson & Liu, 2001; Sinatra, De Leon-Casasola, Ginsberg, & 
Viscusi, 2009).  The utilization of multimodal approach with either a neuraxial block or 
regional block would allow for a decrease in the use of inhalation agents during general 
anesthesia which may reduce the incidence of metastasis (Exadaktylos et al., 2006; 
Heaney & Buggy, 2012; Snyder & Greenberg, 2010).  After viewing a presentation with 
the current data, the CRNAs' willingness to change practice was assessed. 
Problem Statement 
Within healthcare and the implementation of research, a gap exists and is referred 
to as the evidence-practice gap (Kristensen, Nymann, & Konradsen, 2016).  Kristensen 
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and colleagues (2016) define the evidence-practice gap as the prolonged time in which it 
takes for emerging research methods to be translated into practice changes.  The 
existence of the gap allows for the prolonged use of outdated practices.  Integration of 
emerging research into practice change remains a problem in today's healthcare system 
(Kristensen et al., 2016). 
Needs Assessment 
Snyder and Greenberg (2010), found the anesthesia provided perioperatively 
influences the long-term prognosis post-operatively.  Their findings revolve around the 
current knowledge concerning tumor biology and the patient's defense mechanisms.  
Currently, general anesthesia combined with opioids is the approach suggested for the 
anesthesia for mastectomy surgery (Fitzgerald-Macksey, Sowka, Cipcic, Kaufman, & 
Callaway, 2012).  The direct effects of each anesthetic and pharmacologic medication on 
the patient's immune system vary from agent to agent (Nagelhout & Plaus, 2014).  How 
anesthesia and analgesia influences inflammation and the alteration of the immune 
system induced by surgery influencing metastasis is an area of interest within research.  
Some anesthetics and pharmacologic agents such as nitrous oxide and opioids may 
decrease the patient's immune responses while others, such as local anesthetics (LAs) and 
COX inhibitors, may offer benefits for the immune system (Heaney & Buggy, 2012). 
Significance and Implications 
The purpose of this doctoral project was to assess the willingness of CRNAs to 
change practice when presented with a synthesis of current evidence from the literature 
related to anesthesia and metastasis.  CRNAs are positioned to implement change within 
today's health care system.  Implementation of anesthetic techniques which decrease the 
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risk of metastasis for patients will require utilization of pharmacologic agents that are 
beneficial to the patient's immune system.  The implication exists that a CRNA may be 
able to decrease metastasis based on their anesthetic technique (Heaney & Buggy, 2012; 
Snyder & Greenberg 2012).  Nurse anesthetists are educated on the implementation of 
research data, and as new methods become available they should be put into practice. 
Theoretical Framework 
Lewin's change theory (1947) proposes a planned change approach to asserting a 
change within a given system.  A cultural change must permeate all levels of a system.  
This theory affords the ability to implement research into a change in practice.  The 
change must be a change in the cultural atmosphere, not just a change of a single item 
(Burnes, 2004).  Initially, Lewin's change theory was utilized successfully by industries 
in the 1940's to introduce a change in a system or process (Butts & Rich, 2015). 
Industry utilized this theory as a way to implement positive movement increasing 
production.  Lewin portrayed the change as a dynamic force inside an organization that 
pulls in conflicting directions (Lewin, 1947).  Two opposing forces are at work within a 
system change, one that pushes for change, and one resisting the change.  Butts and Rich 
(2015) affirm Lewin viewed change as a balance of these forces, not a single event. 
Lewin's change theory has three distinct phases.  The phases include, unfreezing, 
moving, and refreezing (Lewin, 1947).  In phase one, the new research must be identified 
to spark the change.  The old practice must be discarded and deemed no longer the gold 
standard to allow for further progression.  General anesthesia and opioids must be viewed 
as increasing the risk of metastasis.  Moving into phase two, a change of thought must be 
accomplished within the system.  The change in thought will allow for the proposed idea 
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to replace the old norm.  The new idea must be founded on data that supports the change.  
Multimodal anesthesia and the use of local anesthesia may decrease the risk of metastasis 
(Fodale, D'Arrigo, Triolo, Mondello, & La Torre, 2014).  Lastly, in phase three, the new 
method must become the norm within the culture (Lewin, 1947). 
Doctor of Nursing Practice Essentials 
As a doctoral level nursing capstone project, the doctor of nursing practice (DNP) 
essentials must be met in some way within the project.  The adherence of this doctoral 
level nursing capstone project to the DNP essentials is found in Appendix A.  Each 
essential is listed in the appendix with a brief statement of how the project met the 
essential. 
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CHAPTER II - REVIEW OF THE LITERATURE 
Since the turn of the century, advances have been made in the medical 
understanding of cancer.  Specifically, one area of research examines techniques to 
mitigate the risks associated with the surgical removal of cancer.  Surgical removal of 
primary tumors is a viable option for the treatment of most cancer patients (Cooper, 
2009).  In this literature review, the articles focus on decreasing the risk of metastasis 
associated with anesthetic techniques and pharmacological agents.  Included in the 
review are factors related to the implications of surgical stress, alterations of immune 
status during anesthesia, inhalation agents, opioids and pain management, LAs, and 
multimodal approaches and the impact on the cancer patient.  From this review, a 
conclusion on the modalities which are beneficial or harmful to the mastectomy patient 
population were made. 
Metastasis and Factors of Metastasis 
An understanding of the times at which a tumor cell may metastasize requires a 
description of the process of metastasis.  Briefly, to summarize the metastatic processes 
of a cancerous cell, the cell must detach, migrate, implant, and begin angiogenesis or the 
development of a blood supply for metastasis to occur (Talmadge & Fidler, 2010).  The 
progression of a cancer cell to metastasize is complex and multifactorial with many 
external factors influencing the tumor cell during the process. 
Specific factors noted as possible influences of cancer recurrence are: stimulation 
of cytokine and neuroendocrine stress response; restraint of cell-mediated immunity, 
dispersal of tumor emboli, and the promotion of tumor growth and metastasis (Heaney & 
Buggy, 2012).  Throughout the literature, science supports the idea that over stimulation 
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or suppression of the stress response increases the likelihood of cancer recurrence 
postoperatively (Gottschalk, Sharma, Ford, Durieux, & Tiouririne, 2010).  Heaney and 
Buggy (2012),  echo an earlier postulation by Gottschalk et al. (2010) which draw a 
correlation between the anesthetic events that occur during surgery and metastasis.  
Fodale and colleagues (2014) show in vitro and in vivo studies provide information that 
the patient's physiological response to surgical stress plays a role in the metastatic spread 
of cancer.  A relationship between the patient's response to surgery, anesthetics, and 
possible metastasis becomes evident within the literature. 
Surgical Stress, Immune Status, and Metastasis 
While surgical removal of solid tumors is the core of cancer treatment (Snyder & 
Greenberg, 2010), the need to ameliorate the stresses of the surgical experience exists.  
Surgery imparts stressors on the patient (Exadaktylos et al., 2006; Reiche, Vargas Nunes, 
& Morimoto, 2004).  According to Barash et al. (2009), surgical stress induces the release 
of cytokines and adversely influences the neuroendocrine and sympathoadrenal 
responses.  The actions of surgical stress are detrimental to the physiological responses of 
the patient under anesthesia (Barash et al., 2009).  CRNAs play a role in stress relief of 
the cancer patient (Gottschalk, Sharma, Ford, Durieux, & Tiouririne, 2010).  The stress 
response is vital in healing postoperatively, for over stimulation or suppression of the 
stress response may lead to metastasis (Gottschalk et al., 2010).  Fodale et al. (2014) state 
surgery causes alterations in the stress response, which determine upregulation of 
malignant pathways involved in cancer recurrence.  Inadvertent dispersal of tumor cells 
during surgical manipulation, with a coexisting suppression of cell-mediated immunity, 
and the effects of proangiogenic (factors associated with vascular supply formation) 
 8 
anesthetics are noted as being keys to the dispersion and development of cancer 
recurrence (Heaney & Buggy, 2012).  Through the use of different anesthetics and 
analgesics, the risk of metastasis may be mitigated. 
Surgical stress may cause a decrease in homeostasis of the immune system and 
allow metastasis to occur.  An inference resonating throughout the literature is that 
surgery and the events occurring during the perioperative period decrease immune system 
function (Exadaktylos et al., 2006; Fodale et al., 2014; Heaney & Buggy, 2012; Reiche et 
al., 2004; Snyder & Greenberg, 2010).  The cancer patient's immune system is recognized 
as the primary defense against metastasis (Bar-Yosef et al., 2001).  Recent findings by 
Fodale et al. (2014), suggest that surgery, anesthesia, and analgesia cause 
immunosuppression by secreting proinflammatory and anti-inflammatory cytokines 
promoting the evasion of tumor cells from immune control.  Dewan et al. (2007) and 
Exadaktylos et al. (2006) illustrated the vital role of natural killer (NK) cells, within the 
immune system and their defense against tumor cells.  Prior studies have shown a low 
level of circulating NK cells during the perioperative period is associated with a rise in 
morbidity and mortality in cancer patients (Britenden, Heys, Ross, & Eremin, 1996; 
Vujanovic, Basse, Beberman, & Whiteside, 1996).  With immunological status playing a 
role in metastasis, methods to mitigate the deleterious effects during this time must be 
identified.  A multimodal approach may offer benefits to the surgical mastectomy patient, 
related to a decrease in the amount of perioperative inhalation agent and opioids required. 
Effects of Pharmacological Agents Regarding Metastasis 
Anesthetics and analgesics used during surgery likely have effects beyond the 
perioperative period (Fodale et al., 2014).  Heaney and Buggy (2012), and Gottschalk et 
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al. (2014) both provide specific traits of anesthetic pharmacologic agents and their 
potential effects on the surgical cancer patient.  A synthesis of the information presented 
within the literature reviewed, in regards to pharmacological agents and their effects on 
the host’s immune system and homeostasis is presented in this section. 
Inhalation Agents 
Inhalation anesthetic agents are often used to accomplish general anesthesia 
during surgery.  Sevoflurane and isoflurane are shown to bring on apoptosis 
(programmed cell death) in T-lymphocytes in a manner which has a direct relationship 
with the amount of agent used (Heaney & Buggy, 2012; Loop et al., 2005).  Tedore 
(2015) deduced that inhalation agents were noted to increase pro-angiogenic factors, 
promote hypoxia-inducible factors, and increase cancer cell migration-promoting the 
recurrence of cancer.  Snyder and Greenberg (2010) noted a decrease in NK cells, 
neutrophils, macrophages, dendritic, and impaired T-cell function with inhalation agents.  
Heaney and Buggy noted the implications of nitrous oxide with immune-altering effects 
in the laboratory and clinical studies (Heaney & Buggy, 2012), yet in a study by 
Fleischmann et al. (2009), no significant recurrence in cancer was found while using 
nitrous oxide.  Snyder and Greenberg (2010) correlate nitrous oxide with the inhibition of 
the formation of hematopoietic stem cells (HSCs), which are a factor relevant in tumor 
surveillance.  HSCs promote cell production which may deliver an uninterrupted supply 
of targeted anti-cancer cells (Gschweng, De Oliveire, & Kohn, 2014).  While the 
literature is inconclusive regarding the use of nitrous oxide and the incidence of the 
recurrence of cancer, the literature at this time indicates sevoflurane and isoflurane 
depress the immune system and promote metastasis through their actions. 
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Opioids and Pain Management 
During the perioperative period, opioids are frequently used for the management 
of pain (Heaney & Buggy, 2012).  Opioids can cause inhibition of cellular and humoral 
immunity (Fodale et al., 2014; Gottschalk et al., 2010).  As described earlier, any 
depression in a patient's immune system throughout the operative experience increases 
the risk of cancer recurrence. 
Opioids inhibit cell-mediated immunity and the host's anti-tumor defenses 
including the necessary action of NK cells (Fodale et al., 2014; Snyder & Greenberg, 
2010).  In lab rat studies, Fentanyl has been shown to provide a sharp rise in NK cell 
action during the initial 24 hours perioperatively, yet followed by the increase is a 
prolonged and significant eight-day depression (Forget, Collet, Land’homme, & De 
Kock, 2010).  Morphine, a commonly used opioid postoperatively, may activate vascular 
endothelial growth factors (EGF) (Heaneey & Buggy, 2012).  With the activation of 
EGF, a tumor cell can develop a vascular supply which could promote cancer recurrence 
(Talmadge & Fidler, 2010).  The findings of Heaney and Buggy (2012) corroborate the 
studies on fentanyl and morphine, suggesting opioids have additive deleterious effects in 
the breast cancer patient as they promote cancer cell migration and angiogenesis. 
Decreasing pain throughout the operative experience, without the utilization of 
opioids, affords a patient's immune system optimal effectiveness (Heaney & Buggy, 
2012).  Opioids stimulate tumor growth, promote cell migration, and promote 
angiogenesis, while opioid antagonists exhibit therapeutic effects on cancer progression 
(Fodale et al., 2014).  Taking these actions into account, the use of alternatives to opiates 
in this population could be beneficial. 
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Local Anesthetics 
The use of LAs to decrease perioperative pain and thus reduce the use of opioids 
and inhalation agents requirements during the surgery has been studied.  Le-Wendling, 
Nin, and Capdevila (2016) have found the benefits of LAs in decreasing the recurrence of 
cancer have theoretical basis while also having the support of existing literature.  LAs are 
currently utilized for cancer patients through modalities such as neuraxial anesthesia, 
regional anesthesia and surgical site infiltration (Le-Wendling et al., 2016; Sessler, Ben-
Eliyahu, Mascha, Parat, & Buggy, 2008; Weng et al., 2016).  A neuraxial block is the use 
of LAs injected into an area which targets a nerve root to block the transmission of pain, 
and is accomplished through the use of a spinal or epidural blockade (Nagelhout & Plaus, 
2014).  Regional anesthesia is the injection of LAs around a nerve to block the 
transmission of pain targeting a more localized area of the body (Nagelhout & Plaus, 
2014).  Surgical site injection of LAs can also be used to alleviate the pain experienced 
by a patient postoperatively (Nagelhout & Plaus, 2014).  LA agents also decrease the pain 
a patient experiences (Albi-Feldzer et al., 2013). 
LAs provide a decrease in cancer recurrence based on their anti-proliferative 
effects on neoplastic cells coupled with the decreased need for immune-suppressive 
treatments like opioids (Heaney & Buggy, 2012; Sessler et al., 2008; Snyder & 
Greenberg, 2010).  The finding that LA agents decrease immunosuppression is supported 
by Lucchinetti et al. (2012).  Amide LAs were implicated by Lucchinetti et al. (2012) for 
their impedance on mesenchymal stem cells, which are key players in tumor growth and 
metastasis formation.  Lidocaine was implicated by Snyder and Greenberg, (2010), in 
having a direct inhibitory influence on the endothelial growth factor receptor, which 
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directly inhibits the proliferation of the tumor cell.  The benefits of LAs may be 
appreciated through the use of neuraxial anesthesia, regional or peripheral blocks, and 
surgical site injection. 
The logical deduction can be made that, with a reduction in the pain experienced 
there is a subsequent decline in the need for opioids.  Increased use of LAs, through the 
use of the continuous intercostal block for mastectomy patients, may provide a sharp 
decline in postoperative pain and narcotics needed (M. Herren, personal communication, 
June 3, 2016).  The intercostal block utilized by Dr. Herren provides a continuous 
infusion of ropivacaine, decreasing the patient's pain for three days.  Anecdotally, the 
lack of pain experienced by Dr. Herren's patients is accompanied by a reduction in opioid 
use during the postoperative period.  This anecdotal evidence is supported by the findings 
of Albi-Feldzer et al. (2013).  Furthermore, if the pain is not alleviated, the treatment of 
the pain with opioids can cause a deficit of NK cells and stimulate tumor development 
(Fodale et al., 2014). 
In a meta-analysis of 21 studies conducted by Weng et al. (2016), a significant 
association between neuraxial anesthesia and a decrease in cancer recurrence was 
identified.  The use of LAs attenuated the neuroendocrine stress response, which 
decreased the need for opioids and inhalation agents (Sessler et al., 2008).  The reduction 
in recurrence of metastasis after mastectomy surgery was verified, in a study by Sessler 
and colleagues (2008).  In this study, neuraxial blockade and light sedation were found to 
reduce recurrence when compared to inhalation agents and opioids alone.  When utilized 
with multimodal anesthesia/analgesia, both the techniques of neuraxial and regional 
anesthesia, are reported to increase immune system function. 
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Multimodal Approach 
Sedation during surgery does not have to be accomplished through the use of 
inhalation agents during the perioperative period (Fodale et al., 2014).  Sedation can be 
accomplished through the utilization of other pharmacological agents such as ketamine, 
propofol, thiopental, or alpha-agonists.  Ketamine and thiopental are implicated in 
increasing the number of viable cancer cells while suppressing NK cell activity (Snyder 
and Greenberg, 2010).  Beilin et al. (2007) found ketamine suppressed NK cells while 
attenuating pro-inflammatory cytokines, IL-6, and TNF-α.  Propofol, a commonly used 
anesthetic agent, has not been implicated as a negative influence on the immune system 
(Snyder & Greenberg, 2010).  Das, Kumar, Khanna, and Mehta (2014) promote the use 
of propofol over inhalation agents, for the antitumor effects via inhibition of COX and 
prostaglandins. 
The non-steroidal anti-inflammatory drugs (NSAIDs) restrain prostaglandin 
synthesis through the inhibition of the COX enzyme (Nagelhout & Plaus, 2014).  The 
COX-2 inhibitors are of increasing interest in providing care for the surgical cancer 
patient due to their pharmacodynamics (Snyder & Greenber, 2010).  Inhibition of COX-2 
by celecoxib has been shown to induce apoptosis in tumor cells, delay tumor growth, 
inhibit metastasis, and suppress angiogenesis of metastatic cells  (Leahy et al., 2002).  
COX-2 inhibitors are beneficial considering the over-expression of COX-2 and increase 
in prostaglandins found in a variety of cancers such as colorectal, breast, bladder, 
cervical, and ovarian (Heaney & Buggy, 2012).  White (2016) promotes the use of 
aggressive multimodal techniques during the perioperative period, even without the 
support of prospective clinical data. 
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Conclusion 
The variables which influence the risk of metastasis are numerous, but 
alternatives to inhalation agents with the use of opioids, which may promote metastasis, 
exist.  After synthesizing the current data regarding metastasis in the cancer patient, care 
plans for the surgical cancer patient may be derived.  Optimally, the surgical patient 
would receive no opioids or inhalation agents.  Total intravenous agents provide safer 
anesthesia than inhalation agents.  Pain controlled through the use of LAs, neuraxial or 
regional blockade, and pharmacologic agents such as COX-2 inhibitors and NSAIDs 
provide a decreased risk of metastasis.  The authors of the studies agree on the need for 
further studies surrounding this topic.  The evidence is not supported by prospective 
randomized control trials at this time.  Without the support of strong evidence, such as a 
completed randomized control trial, it is still logical to conclude a multimodal approach 
with refrain from inhalation agents and opioids may help decrease the risk of metastasis.  
The utilization of multimodal analgesic techniques during the perioperative period for the 
surgical cancer patient may offer the most optimal outcome.  The literature reveals, a 
connection for cancer recurrence and the use of opioid analgesics and inhalation agents.  
A multimodal approach if utilized could sever the connection.  A multimodal approach 
decreases the need for inhalation agents and opioids for pain control thus possibly 
reducing the risk of metastasis. 
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CHAPTER III  - METHODOLOGY 
The purpose of this doctoral project was to assess the willingness of CRNAs to 
change practice when presented with a synthesis of current evidence from the literature 
related to anesthesia and metastasis.  Evidence gained from the literature review inferred 
a correlation between metastasis and the possible role of anesthetics and analgesics.  With 
the given evidence, a clinical update was formulated.  The evidence-based update was 
then disseminated to CRNAs, practicing in Mississippi, who were members of the 
Mississippi Association of Nurse Anesthetists (MANA)  via a mass email from MANA. 
Evaluation of the information presented and the impact of the information was analyzed 
using a posthoc survey which was included in the email.  The methodology section of this 
project is in the following order:  1) Sample, 2) Synthesis of Evidence, 3)Dissemination 
of Evidence, 4) Evaluation of Impact on Providers, 5) Methods, 6) Analysis. 
Sample 
A convenience sample consisting of CRNAs who were members of the MANA 
were used for this project.  MANA membership is comprised of nearly 600 nurse 
anesthetists.  MANA was contacted for support of the project and their letter of support is 
attached as Appendix G.  MANA agreed to disseminate an email of the project to all 
CRNAs within the association.  Identified providers were sent an e-mail invitation to 
participate in the project.  Inclusion criteria were limited to members of MANA.  All 
other anesthesia providers were excluded from the project. 
Synthesis of Evidence 
A review of the literature was performed to formulate an evidence-based 
recommendation for anesthesia practice regarding the surgical mastectomy patient 
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population.  The review of the literature was guided by clinical anesthetics and 
analgesics, which influence the surgical mastectomy patient's risk of metastasis.  
Numerous databases were used to identify relevant articles; databases searched include 
CINAHL with full text, MEDLINE, Pubmed, OVID, and Google Scholar.  Keywords 
used included anesthetic influence and cancer long-term survival, anesthesia and breast 
cancer surgery, analgesia and breast cancer surgery, anesthesia and influence and 
metastasis, anesthetic agents and metastasis risk, analgesics and cancer recurrence, 
analgesics and metastatic risk, and the role of anesthesia in cancer prognosis.  Any 
research that discussed anesthetic agents and analgesic techniques concerning metastasis 
probability were included.  Only articles that were peer-reviewed or appeared in 
professional journals and were written in English were included.  Fifty-four articles were 
reviewed for inclusion, and out of those, 15 were found to be viable for inclusion in the 
project.  Only articles produced from 2009-2016 and seminal articles on the topic were 
integrated into this review of literature. 
Dissemination of Evidence 
All CRNAs who were members of MANA received an email inviting them to 
participate in the project.  The email contained a presentation and a link to the survey.  
The results of the synthesis of evidence were shared with the participants, via a succinct 
powerpoint presentation.  The email also contained a link to a Qualtrics survey.  
Participants were made aware that their participation in the survey implied informed 
consent.  The aim of this doctoral project was to identify if a willingness to change 
practice was present in CRNAs when presented with information regarding a possible 
connection between metastasis and anesthesia and analgesia in breast cancer patients. 
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Impact on CRNAs 
The CRNAs viewed a powerpoint presentation and completed a survey about the 
evidence presented.  The presentation and the survey required approximately five to ten 
minutes to complete.  Demographic data along with a self-assessment of the individual 
CRNA's willingness to change practice and identification of barriers that might impede a 
change in practice were collected.  A logic model was constructed to assist in maintaining 
focus on the impact of the project and can be found in Appendix C. 
Strategies 
Within the anesthetic care of this patient population, there are modifiable risk 
factors that may be accomplished by the anesthesia provider to mitigate further risk to the 
patient.  Using Lewin's change theory (1947), unfreezing of outdated practices will occur 
and re-freezing of new evidence-based practice changes will become the norm.  The key 
to implementation of change is identification and recognition of strengths, weaknesses, 
opportunities, and threats (SWOT) to a proposed change (Appendix D). 
Methods 
After obtaining Institutional Review Board (IRB) approval (Appendix E) from the 
University of Southern Mississippi, all CRNAs within the sample were invited to 
participate in the project via e-mail.  The e-mail contained directions for informed 
consent, participation, the abstract of the project, a PowerPoint presentation, and a link to 
the Qualtrics survey.  The presentation highlighted evidence synthesized about anesthetic 
techniques and agents utilized, and their implications on the surgical mastectomy patient 
population.  No specific recommendations to implement change were presented. 
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After viewing the presentation, the CRNAs completed the Qualtrics survey.  A 
single reusable link to the survey was located directly under the link to the presented 
evidence within the email.  The survey was formatted utilizing Qualtrics, a sample of the 
survey questions are found in Appendix F.  The providers were instructed to read the 
questions and answer using a Likert-type scale.  With the scale measurement being: 1) 
strongly disagree, 2) disagree, 3) neutral, 4) agree, and 5) strongly agree.  The survey 
contained forced response questions. The CRNA participants were required to answer the 
previous question to move on to the next question.  The goal of the survey was to identify 
a willingness to change practice in the care of the mastectomy patient by participants. 
Data collected was anonymized.  There were no anticipated risks to participants 
by completing the survey.  The informed consent statement is located in Appendix G. 
Completion of the survey implied informed consent.  The survey was available for two 
calendar weeks (14 days) from the date the emails were disseminated to the participants.  
The timeline was clearly indicated in the email.  Data collected was saved in a password 
encrypted file, and on a dual-password protected laptop. All data collected will be 
destroyed after or on July 1, 2017. 
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CHAPTER IV – ANALYSIS 
The purpose of this doctoral project was to assess the willingness of CRNAs to 
change practice when presented with a synthesis of current evidence from the literature 
related to anesthesia and metastasis.  The participants had access to the synthesis and the 
survey for two weeks.  Data acquired from the Qualtrics surveys was assessed for any 
indication of willingness to change by CRNAs and possible barriers to a practice change. 
After the close of the survey data was analyzed.  The data from the surveys was 
cleaned.  Incomplete surveys were removed from the analysis.  During the survey period, 
34 CRNAs participated in the project by viewing the presentation, and of those 34 
CRNAs, 32 completed the survey.   
Descriptive statistics were used to summarize the sample of 32 using gender, age, 
and years of practice.  The sample of CRNAs who participated in the project consisted of 
19 males (59.4%) and 13 females (40.6%).  Participants in the survey ranged from 27 to 
64 years of age with an average respondent age of 41 years old.  The CRNAs who took 
part in the project had between zero and 39 years of experience in the profession.  Four of 
the CRNAs had zero years of experience.  Ten years of experience was the average years 
of experience was of the CRNAs. 
Results 
The survey questions used a Likert-type scale to assess the participants' responses 
to the survey.  A sample of the survey is found in Appendix F.  Four different questions 
were utilized to assess for a willingness to change practice.   Question four was utilized to 
assess the participant's opinion of the quality of the information.  Question five assessed 
the participants' opinion as to the best method of anesthesia and analgesia for the surgical 
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mastectomy patient. Questions six and seven assessed for a willingness to change their 
current practice.  Question eight was utilized to assess the CRNAs' current practice when 
caring for the surgical mastectomy patient.  
Question 4 
The effectiveness of the presentation was assessed using question four from the 
survey.  The CRNAs were asked if the evidence regarding anesthesia and different 
anesthetic techniques and their relationship to metastasis was presented in an 
understandable way.  Out of the total 32 survey participants, 18 (56.25%) strongly agreed 
while 10 (31.25%) somewhat agreed the information was presented in an understandable 
way.  One participant (3.1%) surveyed did not agree or disagree. A total of three 
participants (9.4%) did not feel the information was presented in an understandable way.  
Question 5 
The opinion of the participants regarding a multimodal approach with a lower 
minimum alveolar concentration (MAC) of inhalation agent or total intravenous 
anesthesia (TIVA) as the best method of anesthesia and analgesia for the mastectomy 
population was assessed using question five.  Overall, 23 CRNAs agreed either strongly 
(34.4%) or somewhat (37.5), that a multimodal approach may be the best method.  The 
nine other participants (28.1%) neither agreed nor disagreed.  
Question 6 
Questions six assessed the participant's willingness to change their practice based 
on the information presented.  The participants were asked, how likely they were to 
change their practice when caring for the mastectomy patient population based of the 
evidence given.  A total of 21 participants agreed they would change their practice; six 
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strongly agreed (18.8%) and 15 somewhat agreed (46.9%).  Seven participants (21.9%) 
neither agreed nor disagreed. While four total participants, three (9.4%) somewhat 
disagreed and one or (3.1%) strongly disagreed that the information given was strong 
enough to change practice. 
Question 7 
The CRNA's opinion regarding the sufficiency of evidence to change practice was 
assessed using question seven.  Of the participants surveyed 18 respondents (56.2%) 
agreed the evidence was sufficient to change practice. Five strongly agreed (15.6%) and 
13 (40.6%) somewhat agreed in the evidence.  Nine CRNAs (28.1%) did not agree or 
disagree. While five (15.6%) participants disagreed with the sufficiency of the evidence. 
Of those that disagreed with the sufficiency of the evidence four (12.5%) somewhat 
disagreed and one (3.1%) strongly disagreed. 
Question 8 
The CRNA's current practice, when providing care to the surgical mastectomy 
patient, was assessed with question eight.  CRNAs were asked to select all methods that 
closely resembled their current practice.  The majority of participants (27 at 84.4%) 
indicated inhalation agents were utilized.  Opioids were utilized by 25 (78.1%) of 
participants.  Local anesthetics were used by 13 (40.6%) of participants.  A multimodal 
approach was indicated as being used by 15 (46.9%) of participants.  Total intravenous 
anesthesia was not used by any of the participants surveyed.  
Discussion 
The purpose of this doctoral project was to assess the willingness of CRNAs to 
change practice when presented with a synthesis of current evidence from the literature 
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related to anesthesia and metastasis.  An overwhelming majority of participants (87.5%) 
believed the material was presented in an understandable way.  Participants indicated 
their current use of anesthesia and analgesia for this patient population included all 
techniques except TIVA. With the majority of participants (84.4%) currently using 
inhalation agents and opioids (78.1%).  After data analysis it became apparent that the 
majority participants (65.6%) were willing to change their practice when caring for the 
surgical mastectomy patient. 
Limitations 
All CRNAs who are members of MANA were invited to participate in the project.  
There are approximately 600 CRNAs who are members of MANA.  With the total 
sample size being 32, a low response rate (5.3%) is noticed.  Given the low response rate 
it is difficult to determine whether the sample correlates with the larger population.   
Future Implications 
CRNAs who participated in the project displayed a willingness to change practice 
when presented with evidence that may improve patient outcomes.  With the majority of 
respondents currently indicating the use of inhalation agents and opioids for this patient 
population, an area for a change is identified.  Further information regarding the role of 
anesthesia and analgesia in metastasis need to be made readily available to CRNAs.  
Conclusion 
The purpose of this project was to identify if a willingness to change practice was 
present in CRNAs after being presented with a synthesis of current evidence from the 
literature related to anesthesia and metastasis.  The overall goal was to incite a change in 
practice within CRNAs when providing care for the surgical mastectomy population.  
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The change must be based on the most current evidence-based research.  Results from the 
survey indicate a willingness to change current practice by 18 of the 32 participants based 
on the evidence presented.   
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APPENDIX A – DNP Essentials 
Doctor of Nursing Essentials How the Essential is Achieved 
I. Scientific Underpinnings for 
Practice 
The utilization of current scientific data 
including the use of lab animal studies 
coupled with a logical approach to 
attempt to solve an issue that hinders 
patient outcomes.   
II. Organizational and Systems 
Leadership for Quality 
Improvement and Systems 
Thinking 
The purpose of this doctoral project is to 
identify the willingness of CRNAs to 
make a change in practice.  To change 
their current practice and improve 
patient outcomes.   
III. Clinical Scholarship and 
Analytical Methods for Evidence-
Based Practice 
Essential III, was met through the 
literature reviewed to synthesize best 
practice.  Analytical methods were used 
when deriving the most appropriate 
methods to care for the population.  
IV. Information Systems/Technology 
and Patient Care Technology for 
the Improvement and 
Transformation of Health Care 
This doctoral project aims to exhibit if a 
willingness exists in changing practice, 
and the generation of the evidence is 
derived from strides in technology.  
V. Health Care Policy for Advocacy 
in Health Care 
Understanding if a provider is willing to 
change current practice regarding the 
mastectomy patient will assist in future 
studies and research on the impact of 
the change and a possible policy 
change.  
VI. Interprofessional Collaboration 
for Improving Patient and 
Population Health Outcomes 
This doctoral project is dependent on 
the effective exchange of information 
and communication regarding the 
anesthetics and analgesics that either 
increases the risk of metastasis or 
decreases the risk of metastasis.    
VII. Clinical Prevention and 
Population Health for Improving 
the Nation’s Health 
Metastasis is a possibility after 
mastectomy surgery.  This project 
revolves around the willingness of 
CRNAs to change their practice 
regarding the interventions that may 
decrease the mastectomy patients risk of 
metastasis. 
VIII. Advanced Nursing Practice The analysis of the latest evidence, the 
synthesis of data, the presentation of the 
synthesized data, and the assessment of 
the impact of the information once 
provided to CRNAs.   
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APPENDIX B – Logic Model 
 
Input Output Outcomes 
 Activities Participation Short Medium Long 
Time 
 
Computer 
Equipment 
and  
Software 
 
University 
Library 
Resources 
Literature 
Review 
 
Personal 
Interviews 
 
Disseminate 
Evidence 
 
Survey 
 
Development 
of 
Presentation 
CRNAs  
who are  
members of 
MANA 
 
 
Increased 
awareness  
of 
anesthesia/ 
analgesia 
role in 
metastasis 
 
Practice 
Change 
Improved 
patient 
satisfaction 
 
Decreased 
patient 
pain post-
operatively 
 
Formation 
of Clinical 
Guideline 
Improved 
patient 
outcomes 
long-term 
 
Information 
extends 
beyond 
mastectomy 
population 
to other 
types of 
cancer 
patients 
 
 
Risks Factors: Provider “buy in”, participants willingness to change, fiscal benefit. 
Assumption: The use of regional anesthesia will be shown to reduce metastasis 
rates in current on-going randomized control trials. 
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APPENDIX C – SWOT 
 
Strengths 
 A strength of the project is the drive that resides within all healthcare providers to 
provide the best care possible to their population.  Once a provider is presented with 
evidence, that if utilized, may positively impact outcomes in the mastectomy patient 
population, they may consider the change of practice. 
Weaknesses 
 A foreseen weakness within the proposed change to practice is there are no 
completed prospective randomized control trials (RCT) despite sound assumptions based 
on stress responses, metastasis, and effects of anesthetic and analgesic methods.  
Opportunities 
Opportunities to implement change evolve as science progresses. With the 
groundwork being laid by numerous studies, systematic reviews, and integrated literature 
reviews, the foundation for change is forming.  The science and data from the reviews 
already accomplished must be presented in a way to maximize the desire to change 
practice.  The completion of an RCT would provide concrete evidence whether general 
anesthesia, with the utilization of opioids for pain relief during the perioperative period, 
is inferior and leads to higher metastasis rates than the use of regional anesthesia and 
lower minimum alveolar concentrations of inhalation agents. 
Threats 
The biggest threat to change related to this project is the "buy-in" of the providers.  
Without the “buy-in” of providers, no willingness to change will be observed. 
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APPENDIX D – Survey 
 
 
 28 
APPENDIX E – Consent 
 
Dear Participant, 
 
On behalf of the University of Southern Mississippi (USM) Nurse Anesthesia Program, 
you are invited to take part in a research study to determine if CRNAs who are shown 
evidence of regional or neuraxial, and multimodal anesthesia decreasing metastasis rates 
are willing to change their practice.   
 
Your participation should be no more than approximately 10 minutes.  There are no 
known risks or discomforts associated with this study, and your participation is 
completely voluntary.  The results from this project could indicate the need for further 
studies into the role of anesthesia and decreasing metastasis rates. 
 
To participate in the study, you are invited to view a PowerPoint presentation with 
regards to current evidence regarding the possible role of anesthesia and analgesia in 
metastasis.  After viewing the presentation, you are invited to take part in an anonymous 
survey.  Each question within the survey must be answered to progress within the survey.  
Your responses will be kept strictly confidential, and digital data will be stored in secure 
computer file after it is entered.  All data collected will be destroyed July 1, 2017.  Any 
report of this research that is made available to the public will not include your name or 
any other identifying information by which you could be identified. You may withdraw 
from the survey at any time without any negative consequences. Completing this survey 
indicates that you are a CRNA.  Your consent to participate in the research is expressed 
by your participation in the survey. 
 
Michael Tillman, a current DNP candidate in the nurse anesthesia program at USM, is 
conducting this project.  Please email any questions or comments to xxx.xxx@usm.edu.  
 
This project has been reviewed and approved by the Institutional Review Board of USM.  
If you have questions, concerns, or want a summary of this project, feel free to contact 
Dr. Marjorie Geisz-Everson, Capstone Chair, at 601-xxx-xxxx, or via email at 
xxx.xxx@usm.edu. 
 
To complete the your participation in the project: 
 
1)  Please download and view the PowerPoint below. 
 
2)  After viewing the PowerPoint please complete this short survey by accessing the link 
below The survey will be open from 12:01 AM on 9/14/2016 until 11:59 on 9/28/2016. 
 
Thank you for your participation in this project. 
Sincerely yours, Michael Tillman BSN, RN, SRNA 
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APPENDIX F – Support Letter 
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APPENDIX G – Question Four and Five 
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APPENDIX H – Question Six and Seven 
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APPENDIX I – Question Eight 
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